Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Conjunctivitis, Allergic”

236 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 236 results

Post-approval studies (Phase 4)Study completedNCT01109485
What this trial is testing

Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients

Who this might be right for
Allergic Conjunctivitis
Alcon Research 42
Large-scale testing (Phase 3)Study completedNCT00424398
What this trial is testing

Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis

Who this might be right for
Conjunctivitis, Allergic
Bausch & Lomb Incorporated 107
Large-scale testing (Phase 3)Study completedNCT02161146
What this trial is testing

AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis

Who this might be right for
Conjunctivitis, Allergic
Allergan 240
Testing effectiveness (Phase 2)Study completedNCT02082899
What this trial is testing

A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1)

Who this might be right for
Allergic Conjunctivitis
Eleven Biotherapeutics 150
Large-scale testing (Phase 3)Study completedNCT01698814
What this trial is testing

A Six-Week Safety Study of an Investigational Ophthalmic Solution

Who this might be right for
Allergic Conjunctivitis
Alcon Research 518
Large-scale testing (Phase 3)Study completedNCT02132169
What this trial is testing

A Multi-Center Study Evaluating the Safety of AC-170 0.24%

Who this might be right for
Atopic Disease (Including Allergic Conjunctivitis)
Aciex Therapeutics, Inc. 512
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07169695
What this trial is testing

Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis

Who this might be right for
Moderate to Severe Vernal Keratoconjunctivitis
Laboratoires Thea 120
Post-approval studies (Phase 4)Ended earlyNCT00276445
What this trial is testing

Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan

Who this might be right for
Allergic Conjunctivitis
Meiji University of Oriental Medicine 60
Large-scale testing (Phase 3)Study completedNCT05579730
What this trial is testing

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis
Bausch & Lomb Incorporated 188
Very early researchStudy completedNCT04418999
What this trial is testing

Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus

Who this might be right for
KeratoconusDry EyeAllergy
Illinois College of Optometry 36
Large-scale testing (Phase 3)Study completedNCT00432757
What this trial is testing

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis
Vistakon Pharmaceuticals 120
Large-scale testing (Phase 3)Study completedNCT02492321
What this trial is testing

A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis (AC)
Eleven Biotherapeutics 250
Post-approval studies (Phase 4)Study completedNCT00891436
What this trial is testing

Study of the Effect of Fluticasone Furoate Nasal Spray on Spring Allergy Eye Symptoms

Who this might be right for
Allergic Conjunctivitis to Tree Pollen or Grass Pollen
Rush University Medical Center 20
Not applicableStudy completedNCT02295969
What this trial is testing

Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis

Who this might be right for
Allergy
Stallergenes Greer 307
Not applicableStudy completedNCT04984941
What this trial is testing

Evaluation of the Role of IgE Responses to Der p 1 and Der p 2 in Chinese House Dust Mite-Allergic Patients

Who this might be right for
AsthmaAllergic RhinitisConjunctivitis+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 100
Early research (Phase 1)Study completedNCT07042828
What this trial is testing

To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting Conditions

Who this might be right for
Allergic Rhino-ConjunctivitisUrticaria
Humanis Saglık Anonim Sirketi 42
Not applicableActive Not RecruitingNCT07385495
What this trial is testing

OJO-miR: microRNA Expression in Allergic Conjunctivitis.

Who this might be right for
Conjunctivitis, Allergic
Instituto de Oftalmología Fundación Conde de Valenciana 40
Post-approval studies (Phase 4)Study completedNCT06800274
What this trial is testing

Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film Dysfunction

Who this might be right for
Allergic ConjunctivitisDry Eye Disease (DED)
Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona 134
Large-scale testing (Phase 3)Study completedNCT00569777
What this trial is testing

Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers

Who this might be right for
Allergic Conjunctivitis
Vistakon Pharmaceuticals 310
Post-approval studies (Phase 4)Study completedNCT00689078
What this trial is testing

Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model

Who this might be right for
Allergic Conjunctivitis
ORA, Inc. 36
Load More Results